Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
Sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: Sick). The outcome of the sickness was not reported. The reporter considered the sickness to be related to Shingles vaccine. The company considered the sickness to be related to Shingles vaccine. Linked case(s) involving the same patient:US2025AMR137993 Additional Information: GSK receipt date: 22-OCT-2025 The patient received Shingles vaccine and got sick from them. For tolerance of 2nd dose of Shingles vaccine, refer case US2025AMR137993.; Sender's Comments: US-GSK-US2025AMR137993:Same patient (second dose)